A Study of Mirikizumab in Participants With Plaque Psoriasis

NCT03718884 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Drug Cocktail
DRUG: Mirikizumab

Sponsor

Eli Lilly and Company